Insmed Inc (INSM)vsPharming Group NV (PHAR)
INSM
Insmed Inc
$148.31
+6.59%
HEALTHCARE · Cap: $29.99B
PHAR
Pharming Group NV
$16.23
+1.63%
HEALTHCARE · Cap: $1.11B
Smart Verdict
WallStSmart Research — data-driven comparison
Insmed Inc generates 61% more annual revenue ($606.42M vs $376.13M). PHAR leads profitability with a 0.8% profit margin vs -2.1%. PHAR earns a higher WallStSmart Score of 39/100 (F).
INSM
Hold39
out of 100
Grade: F
PHAR
Hold39
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for INSM.
Margin of Safety
-732.6%
Fair Value
$1.87
Current Price
$16.23
$14.36 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
No standout strengths identified
Earnings expanding 98.1% YoY
Areas to Watch
1.5% revenue growth
0.0% earnings growth
Trading at 43.0x book value
ROE of -2.5% — below average capital efficiency
Smaller company, higher risk/reward
ROE of 1.0% — below average capital efficiency
0.8% margin — thin
Premium valuation, high expectations priced in
Comparative Analysis Report
WallStSmart ResearchBull Case : INSM
PEG of 1.09 suggests the stock is reasonably priced for its growth.
Bull Case : PHAR
The strongest argument for PHAR centers on EPS Growth. Revenue growth of 14.9% demonstrates continued momentum.
Bear Case : INSM
The primary concerns for INSM are Revenue Growth, EPS Growth, Price/Book.
Bear Case : PHAR
The primary concerns for PHAR are Market Cap, Return on Equity, Profit Margin. A P/E of 399.3x leaves little room for execution misses. Thin 0.8% margins leave little buffer for downturns.
Key Dynamics to Monitor
INSM profiles as a turnaround stock while PHAR is a value play — different risk/reward profiles.
INSM carries more volatility with a beta of 1.17 — expect wider price swings.
PHAR is growing revenue faster at 14.9% — sustainability is the question.
PHAR generates stronger free cash flow (6M), providing more financial flexibility.
Bottom Line
INSM scores higher overall (39/100 vs 39/100). Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Insmed Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Insmed Incorporated, a biopharmaceutical company, develops and markets therapies for patients with rare and serious diseases. The company is headquartered in Bridgewater, New Jersey.
Pharming Group NV
HEALTHCARE · BIOTECHNOLOGY · USA
Pharming Group NV, a specialty pharmaceutical company, develops products for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. The company is headquartered in Leiden, the Netherlands.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?